InfuSystem Holdings (INFU) EBITDA Margin (2010 - 2026)

InfuSystem Holdings has reported EBITDA Margin for 17 years, with the latest figure at 3.05% in Q1 2026.

• For the quarter ending Q1 2026, EBITDA Margin rose 454.0% year-over-year to 3.05%; the trailing twelve-month figure through Mar 2026 stood at 5.35% (up 334.0% YoY), and the FY2025 full-year result was 4.23%, up 247.0% from the prior year.
• EBITDA Margin for Q1 2026 stood at 3.05%, down from 5.41% in the prior quarter.
• The five-year high for EBITDA Margin was 6.79% in Q2 2025, with the low at 2.83% in Q1 2024.
• Historically, EBITDA Margin has averaged 1.91% across 5 years, with a median of 2.12% in 2024.
• Annual changes were most pronounced in 2023 — EBITDA Margin slumped 298 bps — and 2024, when it soared 508 bps.
• InfuSystem Holdings' EBITDA Margin stood at 0.01% in 2022, then tumbled by 14237 bps to 1.49% in 2023, then jumped by 341 bps to 3.59% in 2024, then surged by 51 bps to 5.41% in 2025, then sank by 44 bps to 3.05% in 2026.
• The last three EBITDA Margin figures came in at 3.05% (Q1 2026), 5.41% (Q4 2025), and 5.99% (Q3 2025), per Business Quant data.